APYX News and Press, Apyx Medical Corporation From 11/09/20

Apyx Medical Corporation (APYX) Q3 2020 Earnings Conference Call November 9, 2020 08:00 ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants David Turkaly - JMP Securities Matthew O’Brien - Pipe...

Apyx Medical (APYX): Q3 GAAP EPS of -$0.11 beats by $0.06.Revenue of $6.95M (-8.3% Y/Y) beats by $1.27M.Press Release For further details see: Apyx Medical EPS beats by $0.06, beats on revenue

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and J-Plasma ® in the hospital surgical marke...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and J-Plasma ® in the hospital surgical marke...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and J-Plasma ® in the hospital surgical marke...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today...

Apyx Medical Corporation (APYX) Q2 2020 Results Earnings Conference Call August 10, 2020, 08:00 AM ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Mat...

Apyx Medical (NASDAQ: APYX ) : Q2 GAAP EPS of -$0.14 beats by $0.07 . More news on: Apyx Medical Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and J-Plasma ® in the hospital surgical market, today repor...